Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,123.3
-21.0 (-0.67%)

 

  • STI Straits Times Index
    3,123.3
    -21.0 (-0.67%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,582.5
    4.9 (0.31%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,028.3
    -202.7 (-0.72%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,444.3
    -18.4 (-0.53%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,628.7
    -518.8 (-1.84%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,975.8
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,387.6M
  • Value: 1,468.4M
  • Rise: 151
  • Fall: 160
  • Unch: 465

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.191+0.001
Golden Agri-Res0.275+0.015
Advanced Systems0.001-
Jiutian Chemical0.098+0.003
AP Strategic0.003+0.001
ThaiBev0.695-0.015
Suntec Reit1.490-0.010
Singtel2.410-0.010
Shen Yao0.009-
VCPlus0.028-0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,031.7 -357.7
HSI 27,980.2 -250.9
HSCEI 10,443.6 -113.0
Jakarta 5,975.8
Nikkei 225 27,628.7 -518.8
SSE Comp 3,440.0 -22.8
Shanghai A 3,605.6 -23.9
Shanghai B 250.2 -1.1
KOSPI 3,161.4 -0.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MATINAS BIOPHARMA HOLDINGS INC MATINAS BIOPHARMA HOLDINGS INC
Updated on 12 May 2021 (End of trading day)
Last (USD): 0.753 Change: -0.058 High: 0.810 Remarks: -
Change (%): -7.10 Low: 0.750
Open 0.790 Yesterday's Close 0.8110999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 881,880 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.25269 Trailing EPS (USD) e -0.25269 NAV (USD) b 0.6516
PE a - Trailing PE f - Price / NAV b 1.1564
Dividend (USD) d - Cash In Hand (USD) g 0.1367 Issued & Paid-up Shares c 204,276,000
Dividend Yield (%) d - Price / Cash In Hand g 5.512 Treasury Shares h -
Market Cap (M) 69.301 Enterprise Value (M) 18.034
Piotroski F Score 2 Exchange Code MTNB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 78.36 Free Float (%) 87.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Mar 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MATINAS BIOPHARMA HOLDINGS INC NYSE American 69.301 - - 1.1564 -
Industry Biotechnology NYSE American 166.646 - - 3.8988 -
Local Peer ACTINIUM PHARMACEUTICALS INC NYSE American 574.551 - - 9.3697 -
Local Peer 22ND CENTURY GROUP INC NYSE American 406.930 - - 9.2243 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 366.918 - - 3.8138 -
Local Peer NANOVIRICIDES INC NYSE American 210.030 - - 7.5699 -
Local Peer CEL-SCI CORP NYSE American 185.973 - - 6.4493 -
Local Peer IBIO INC NYSE American 137.372 - - 1.2798 -
Local Peer BIOMX INC NYSE American 138.319 - - 2.4068 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 100.011 - - 5.3035 -
Local Peer AIM IMMUNOTECH INC NYSE American 96.122 - - 1.5872 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 75.851 - - 1.1183 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 63.033 - - -8.6991 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 40.355 - - 1.8795 -
Other Local Peers CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ORAGENICS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 144,115.380 19.840 20.341 15.4399 2.568
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 124,816.660 39.797 32.797 11.8115 1.070
Global Peer GILEAD SCIENCES INC NASDAQ 84,594.441 687.774 281.045 4.4608 4.032
Global Peer MODERNA INC NASDAQ 61,305.295 - 102.489 15.9732 -
Global Peer ILLUMINA INC NASDAQ 54,434.640 82.980 86.404 11.0595 -
Global Peer WUXI BIO HKEx 440,846.095 232.293 232.294 18.0808 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,055.621 20.303 19.933 6.1307 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 54,032.709 15.380 13.495 4.5114 -
Global Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 44,954.304 2,594.870 474.671 - -
Other Global Peers BIOGEN INC (NASDAQ), ALEXION PHARMACEUTICAL INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), SEAGEN INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIO-TECHNE CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ZAI LAB-SB (HKEx), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), GENSCRIPT BIO (HKEx), TWIST BIOSCIENCE CORPORATION (NASDAQ), JOINN (HKEx), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), Lonza (SGX), KODIAK SCIENCES INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ARVINAS INC (NASDAQ), KINTOR PHARMA-B (HKEx), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), 3SBIO (HKEx), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), NUVATION BIO INC (NYSE), ORGANOGENESIS HOLDINGS INC (NASDAQ), XENCOR INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ALPHAMAB-B (HKEx), NGM BIOPHARMACEUTICALS INC (NASDAQ), INSTIL BIO INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), KYMERA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), OCUGEN INC (NASDAQ), SEER INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), JACOBIO-B (HKEx), MACROGENICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), MORPHIC HOLDING INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), VIVA BIOTECH (HKEx), BIOATLA INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), HAOHAI BIOTEC (HKEx), SANGAMO THERAPEUTICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), IMMUNOVANT INC (NASDAQ), UNIQURE N.V. (NASDAQ), ALLOVIR INC (NASDAQ), JW THERAP-B (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), ASCENTAGE-B (HKEx), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), POLYNOVO LIMITED (ASX), PRECIGEN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ALECTOR INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), EDGEWISE THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), AFFIMED N V (NASDAQ), MANNKIND CORPORATION (NASDAQ), MIMEDX GROUP INC (NASDAQ), HUMANIGEN INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), JHBP-B (HKEx), IMUGENE LIMITED (ASX), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), VAXCYTE INC (NASDAQ), MESOBLAST LTD (ASX), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VOR BIOPHARMA INC (NASDAQ), EPIZYME INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERUS B V (NASDAQ), PERSONALIS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), VAXART INC (NASDAQ), NKARTA INC (NASDAQ), TELIX PHARMACEUTIC (ASX), BIOXCEL THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ANAPTYSBIO INC (NASDAQ), CHIMERIX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AGENUS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), IMMATICS N V (NASDAQ), ARDELYX INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), INHIBRX INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), COMPUGEN (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), IVERIC BIO INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), DPHARMA (Bursa), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), AKOUOS INC (NASDAQ), ANTEOTECH LIMITED (ASX), GERON CORP (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ASCLETIS-B (HKEx), CUE BIOPHARMA INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), SINOMAB BIO-B (HKEx), SESEN BIO INC (NASDAQ), ADICET BIO INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ESSEX BIO-TECH (HKEx), TERNS PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCORUS INC (NASDAQ), OPTHEA LIMITED (ASX), ATRECA INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVROBIO INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), LEE'S PHARM (HKEx), PARATEK PHARMACEUTICALS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), NEXT SCIENCE LTD (ASX), TREVENA INC (NASDAQ), IMMUTEP LTD (ASX), KEZAR LIFE SCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CHIASMA INC (NASDAQ), CABALETTA BIO INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOVIE INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), SAVARA INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), IMV INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), BIONOMICS LTD (ASX), T2 BIOSYSTEMS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), INMUNE BIO INC (NASDAQ), INFLARX N V (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), EVOGENE LTD (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), LONGEVERON INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), METACRINE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), LEAF RESOURCES LTD (ASX), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), UNI-BIO GROUP (HKEx), PRECIPIO INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), COHBAR INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), NEUROBO PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), ADVAXIS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), CT ENTERPRISE (HKEx), IDERA PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), ARCA BIOPHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), SOLIGENIX INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), PALISADE BIO INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), MEMPHASYS LTD (ASX), GEOVAX LABS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), HISTOGEN INC (NASDAQ), Suntar Eco-City (SGX), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), BIOTRON (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BIOSINO BIO-TEC (HKEx), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), REGENEUS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CRYOSITE (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.051
-6.28 %
10 Days --0.185
-19.76 %
20 Days --0.137
-15.34 %
Medium Term Return 3 Months --0.666
-46.94 %
6 Months --0.051
-6.40 %
1 Year -+0.021
+2.80 %
Long Term Return 2 Years --0.183
-19.50 %
3 Years -+0.201
+36.26 %
Annualised Return Annualised --
+10.86 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.661 - 2.220 Change From 1 Year Low +0.092 % Change From 1 Year Low (%) +13.99
Change From 1 Year High -1.466 % Change From 1 Year High (%) -66.06
2 Years Range 0.490 - 2.490 Change From 2 Years Low +0.264 % Change From 2 Years Low (%) +53.78
Change From 2 Years High -1.736 % Change From 2 Years High (%) -69.74
5 Years Range 0.324 - 3.950 Change From 5 Years Low +0.430 % Change From 5 Years Low (%) +132.78
Change From 5 Years High -3.196 % Change From 5 Years High (%) -80.92
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. Its anti-fungal product candidate, MAT2203, delivers broad-spectrum fungicidal agent, amphotericin B, and is being developed to prevent invasive fungal infections in patients with acute lymphoblastic leukemia. The company was founded by Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
12 May 2021 0.790 0.810 0.750 0.753 881,880 -
11 May 2021 0.729 0.820 0.721 0.811 1,057,253 -
10 May 2021 0.810 0.815 0.750 0.769 1,426,359 -
07 May 2021 0.800 0.829 0.781 0.791 1,209,822 -
06 May 2021 0.830 0.837 0.790 0.804 1,359,647 -
05 May 2021 0.850 0.889 0.792 0.838 2,988,587 -
04 May 2021 0.860 0.880 0.850 0.863 1,429,480 -
03 May 2021 0.866 0.905 0.866 0.880 973,063 -
30 Apr 2021 0.937 0.937 0.870 0.880 1,732,323 -
29 Apr 2021 0.967 0.980 0.922 0.939 542,187 -
28 Apr 2021 0.930 0.970 0.902 0.964 658,034 -
27 Apr 2021 0.950 0.950 0.911 0.930 997,029 -
26 Apr 2021 0.890 0.930 0.880 0.910 889,482 -
23 Apr 2021 0.860 0.906 0.860 0.885 841,708 -
22 Apr 2021 0.910 0.920 0.850 0.880 1,083,426 -
21 Apr 2021 0.840 0.879 0.840 0.863 967,716 -
20 Apr 2021 0.861 0.889 0.820 0.850 1,481,880 -
19 Apr 2021 0.877 0.911 0.875 0.880 932,597 -
16 Apr 2021 0.880 0.929 0.850 0.901 2,174,594 -
15 Apr 2021 0.940 0.954 0.880 0.890 1,785,750 -
14 Apr 2021 0.950 0.960 0.910 0.940 2,297,600 -
13 Apr 2021 0.970 0.990 0.950 0.971 907,183 -
Summary
Current 2 Weeks
(29 Apr 2021 to 12 May 2021)
0.967 0.980 0.721 0.754 13,600,601 -
Previous 2 Weeks
(15 Apr 2021 to 28 Apr 2021)
0.940 0.980 0.721 0.964 11,812,216 -
4 Weeks from
(17 Mar 2021 to 14 Apr 2021)
1.120 1.180 0.721 0.940 32,194,753 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.